Time to Treatment and Acute Coronary Syndromes: Bridging the Gap in Rapid Decision Making

被引:4
|
作者
Peacock, W. Frank [1 ]
机构
[1] Cleveland Clin Fdn, Dept Emergency Med, Cleveland, OH 44195 USA
关键词
Acute coronary syndromes; B-type natriuretic peptide; Cardiac troponin; NATRIURETIC PEPTIDE LEVELS; ST-SEGMENT ELEVATION; CARDIAC TROPONIN-T; MYOCARDIAL-INFARCTION; CHEST-PAIN; RISK STRATIFICATION; PROGNOSTIC VALUE; ARTERY-DISEASE; INVASIVE STRATEGY; UNSTABLE ANGINA;
D O I
10.3909/ricm11S2S0001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The role of cardiac biomarkers in the diagnosis, risk stratification, and treatment of patients with chest pain and suspected acute coronary syndromes (ACS) has continued to evolve. Although it is clear that troponin (Tn) measurement provides independent prognostic information in patients with suspected ACS, it is less well established that early B-type natriuretic peptide (BNP) measurement provides additional incremental prognostic information above and beyond electrocardiography and Tn measurement. It is use flu to identify patients at high risk for adverse events through measurement of Tn and BNP levels so that timely treatment decisions can be made. [Rev Cardiovasc Med. 2010;11(suppl 2):S45-S50 doi: 10.3909/ricm11S2S0001] (C) 2010 MedReviews (R), LLC
引用
收藏
页码:S45 / S50
页数:6
相关论文
共 50 条